# Hypotonic Versus Isotonic Parenteral (HIP) Fluid Trial

> **NCT00734214** · PHASE3 · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 258 (actual)

## Conditions studied

- Hyponatremia
- Hypernatremia

## Interventions

- **DRUG:** 0.9% NaCl
- **DRUG:** 0.45%NaCl

## Key facts

- **NCT ID:** NCT00734214
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2015-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00734214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00734214, "Hypotonic Versus Isotonic Parenteral (HIP) Fluid Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00734214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*